The product line, which is made in-house at WeedMD’s extraction hub CX Industries, will be available to medical patients in coming weeks, the group said.
It will also be rolled out into the adult-use market under the Color Cannabis brand in the third quarter of this year, said WeedMD.
The product will initially launch with the Ghost Train Haze strain, followed by Mango Haze and soon after a high CBD-strain format.
"Our Cannabis 2.0 strategy evolved after thoughtful consideration of our medical clients’ need for relief from specific indications that may require precise cannabis dosing via alternate delivery methods,” Angelo Tsebelis, the chief executive of WeedMD, said in a statement.
"When paired with our in-house talent in cultivating, extracting, and processing, we developed Aurum as a perfect alternative consumption method. In keeping with our medical roots, we are proud to launch Aurum as a refined medical product that complements our quality-produced portfolio."
The Aurum vape hardware is powered by New York-based Blinc Group, designers of premium customized vaporizers, highlighted WeedMD.
"Aurum is the finished product of many months of testing, perfecting formulations and collaborating between our team and our partner, the Blinc Group, to ensure we deliver a safe and high-quality product to our patients," added Moe Jiwan, chief customer officer at the firm.
The ‘Aurum’ vapes are available to the group's subsidiary Starseed Medicinal Inc's patients across Canada as part of WeedMD's expanding medical cannabis product portfolio as an insured benefit.
WeedMD Inc is the parent company of WeedMD RX Inc and Starseed Medicinal Inc federally-licensed producers of cannabis products for both the medical and adult-use markets.
Contact the author at [email protected]